SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:liu-143603"
 

Sökning: id:"swepub:oai:DiVA.org:liu-143603" > The impact of supra...

The impact of supraventricular ectopic complexes in different age groups and risk of recurrent atrial fibrillation after antiarrhythmic medication or catheter ablation

Alhede, Christina (författare)
Herlev Gentofte University Hospital, Denmark
Lauridsen, Trine K. (författare)
Herlev Gentofte University Hospital, Denmark
Johannessen, Arne (författare)
Herlev Gentofte University Hospital, Denmark
visa fler...
Dixen, Ulrik (författare)
Hvidovre University Hospital, Denmark
Jensen, Jan S. (författare)
Herlev Gentofte University Hospital, Denmark
Raatikainen, Pekka (författare)
Helsinki University Hospital, Finland
Hindricks, Gerhard (författare)
Leipzig University Hospital, Germany
Walfridsson, Håkan (författare)
Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US
Kongstadf, Ole (författare)
Lund University Hospital, Sweden
Pehrson, Steen (författare)
Rigshosp, Denmark
Englund, Anders (författare)
Örebro University Hospital, Sweden
Hartikainen, Juha (författare)
Kupio University Hospital, Finland
Hansen, Peter S. (författare)
Varde Heart Centre, Denmark
Nielsen, Jens C. (författare)
Aarhus University Hospital, Denmark
Jons, Christian (författare)
Rigshosp, Denmark
visa färre...
 (creator_code:org_t)
ELSEVIER IRELAND LTD, 2018
2018
Engelska.
Ingår i: International Journal of Cardiology. - : ELSEVIER IRELAND LTD. - 0167-5273 .- 1874-1754. ; 250, s. 122-127
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Introduction: Supraventricular ectopic complexes (SVEC) are known risk factors of recurrent atrial fibrillation (AF). However, the impact of SVEC in different age groups is unknown. We aimed to investigate the risk of AF recurrence with higher SVEC burden in patients +/- 57 years, respectively, after treatment with antiarrhythmic medication (AAD) or catheter ablation (CA). Methods: In total, 260 patients with LVEF amp;gt;40% and age amp;lt;= 70 years were randomized to AAD (N = 132) or CA (N = 128) as first-line treatment for paroxysmal AF. All patients underwent 7-day Holter monitoring at baseline, and after 3, 6, 12, 18 and 24 months and were categorized according to median age +/- 57 years. We used multi-variate Cox regression analyses and we defined high SVEC burden at 3 months of follow-up as the upper 75th percentile amp;gt;195 SVEC/day. AF recurrence was defined as AF amp;gt;= 1 min, AF-related cardioversion or hospitalization. Results: Age amp;gt;57 years were significantly associated with higher AF recurrence rate after CA (58% vs 36%, p = 0.02). After CA, we observed a higher SVEC burden during follow-up in patients amp;gt;57 years which was not observed in the younger age group treatedwith CA (p = 0.006). High SVEC burden at 3 months after CA was associated with AF recurrence in older patients but not in younger patients (amp;gt;57 years: HR 3.4 [1.4-7.9], p = 0.005). We did not find any age-related differences after AAD. Conclusion: We found that younger and older patients respond differently to CA and that SVEC burden was only associated with AF recurrence in older patients. (C) 2017 Elsevier B.V. All rights reserved.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

Arrhythmia; Age; Treatment; Recurrence; Premature ectopic beats

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy